Inibsa

Inibsa is a pharmaceutical company based in Barcelona with 75 years of experience in the market. They specialize in providing products and services to dental professionals and have established themselves as a reference in Spain and Portugal, with a presence in over 60 countries. Inibsa has continuously adapted to incorporate the latest technologies into their manufacturing process and quality control to maintain their leadership in the industry. With a focus on innovation and internationalization, they have positioned themselves as a competitive, sustainable, and committed group. Inibsa boasts world-class R&D and manufacturing facilities and operates with a team of over 375 members of staff. They have the capability of producing over 1 million cartridges a day, showcasing their extensive manufacturing capacity. Founded in 1948, Inibsa's presence spans Health Care, Manufacturing, and Pharmaceutical industries, indicating their diverse reach and expertise. Overall, Inibsa presents itself as a well-established player in the pharmaceutical industry with a strong emphasis on innovation, quality, and international expansion, making it an attractive prospect for potential investors. Although details of their last investment and specific investors are not available, their track record and market presence make Inibsa an intriguing opportunity for venture capital investment.